BridgeMD
New treatment option for Pediatric Hematologic Malignancies
Official title CANUT Junior : Assessment of Sensory Abilities and Eating Behavior in Pediatric Oncology: a Feasibility Study
ClinicalTrials.gov ID: NCT07632560
What this study is testing
- What it's testing
- Cancer treatments in children are very intense and often cause side effects such as nausea, vomiting, loss of appetite, and changes in taste and smell. These sensory alterations can impact eating habits, but they are still poorly understood in children.
- Time commitment: about 5 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 17
You may be able to join if
- Patients treated at a pediatric oncology-hematology center, with an initial diagnosis of a solid or hematological tumor, aged 7 to 17 years inclusive.
- Patients with functional oral feeding
- Parent/guardian who has signed the informed consent form and patient who has not expressed refusal
- Patients affiliated with the social security system
- French-speaking patients
You likely can't join if
- Individuals with a known food allergy/intolerance to the prototypes being studied (does not apply to patients on a protected diet)
- Individuals who have undergone surgery on the tongue
- Patients for whom other types of cancer treatment are planned during the study period (e.g., radiation therapy)
- Patients with dental conditions
- Patients who have relapsed
See the full eligibility criteria
- Patients treated at a pediatric oncology-hematology center, with an initial diagnosis of a solid or hematological tumor, aged 7 to 17 years inclusive.
- Patients with functional oral feeding
- Parent/guardian who has signed the informed consent form and patient who has not expressed refusal
- Patients affiliated with the social security system
- French-speaking patients
- Validated indication for systematic oncological treatment
- Individuals with a known food allergy/intolerance to the prototypes being studied (does not apply to patients on a protected diet)
- Individuals who have undergone surgery on the tongue
- Patients for whom other types of cancer treatment are planned during the study period (e.g., radiation therapy)
- Patients with dental conditions
- Patients who have relapsed
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.